3.185 USD
-0.12 (-3.78%)
ChartMill assigns a Buy % Consensus number of 83% to QNCX. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 7.82. This target is 145.53% above the current price.
- QNCX was analyzed by 12 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about QNCX.
- In the previous month the buy percentage consensus was at a similar level.
- QNCX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-15 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-13 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-09-26 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-15 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-12 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-08-05 | JMP Securities | Initiate | Market Outperform |
| 2025-07-17 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-13 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-04 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-25 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-24 | Oppenheimer | Initiate | Outperform |
| 2025-02-05 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-01-02 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-12-18 | Brookline Capital | Initiate | Buy |
| 2024-11-14 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-11-12 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-11-07 | Maxim Group | Initiate | Buy |
| 2024-10-29 | Rodman & Renshaw | Initiate | Buy |
| 2024-10-22 | EF Hutton | Initiate | Buy |
QUINCE THERAPEUTICS INC / QNCX FAQ
Can you provide the average price target for QUINCE THERAPEUTICS INC stock?
12 analysts have analysed QNCX and the average price target is 7.82 USD. This implies a price increase of 145.53% is expected in the next year compared to the current price of 3.185.
Can you provide the consensus rating for QUINCE THERAPEUTICS INC stock?
The consensus rating for QUINCE THERAPEUTICS INC (QNCX) is 83.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed QUINCE THERAPEUTICS INC (QNCX)?
The number of analysts covering QUINCE THERAPEUTICS INC (QNCX) is 12.